KTTA CIK: 1841330

Pasithea Therapeutics Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY22
millions USD
FY21:
0.00
FY22:
0.37
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.51
FY22:
−0.21
FY23:
−16.0
FY24:
−14.2
FY25:
−20.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.51
FY22:
–
FY23:
−15.4
FY24:
−13.5
FY25:
−19.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.17
FY22:
−13.9
FY23:
−15.5
FY24:
−13.9
FY25:
−20.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.17
FY22:
−13.9
FY23:
−16.0
FY24:
−13.9
FY25:
−20.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data